Purpose To determine whether use of the liver surface nodularity (LSN) score, a quantitative biomarker derived from routine computed tomographic (CT) images, allows prediction of cirrhosis decompensation and death. Materials and Methods For this institutional review board-approved HIPAA-compliant retrospective study, adult patients with cirrhosis and Model for End-Stage Liver Disease (MELD) score within 3 months of initial liver CT imaging between January 3, 2006, and May 30, 2012, were identified from electronic medical records (n = 830). The LSN score was measured by using CT images and quantitative software. Competing risk regression was used to determine the association of the LSN score with hepatic decompensation and overall survival. A risk model combining LSN scores (<3 or ≥3) and MELD scores (<10 or ≥10) was created for predicting liver-related events. Results In patients with compensated cirrhosis, 40% (129 of 326) experienced decompensation during a median follow-up period of 4.22 years. After adjustment for competing risks including MELD score, LSN score (hazard ratio, 1.38; 95% confidence interval: 1.06, 1.79) was found to be independently predictive of hepatic decompensation. Median times to decompensation of patients at high (1.76 years, n = 48), intermediate (3.79 years, n = 126), and low (6.14 years, n = 152) risk of hepatic decompensation were significantly different (P < .001). Among the full cohort with compensated or decompensated cirrhosis, 61% (504 of 830) died during the median follow-up period of 2.26 years. After adjustment for competing risks, LSN score (hazard ratio, 1.22; 95% confidence interval: 1.11, 1.33) and MELD score (hazard ratio, 1.08; 95% confidence interval: 1.06, 1.11) were found to be independent predictors of death. Median times to death of patients at high (0.94 years, n = 315), intermediate (2.79 years, n = 312), and low (4.69 years, n = 203) risk were significantly different (P < .001). Conclusion The LSN score derived from routine CT images allows prediction of cirrhosis decompensation and death. RSNA, 2016 Online supplemental material is available for this article.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1148/radiol.2016160799 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Impact of the COVID-19 pandemic on outcomes of acute ischemic stroke patients treated with endovascular therapy: A multicenter Canadian study.
PLoS One
February 2025
Department of Radiology, Radiation Oncology and Medical Physics and Department of Surgery, Section of Interventional Neuroradiology, The Ottawa Hospital, University of Ottawa, Ottawa, Ontario, Canada.
Objective: The novel coronavirus disease 2019 (COVID-19) pandemic led to the implementation of wide-ranging institutional infection control protocols. The purpose of this study is to determine the effect of the pandemic on outcomes of large vessel occlusion (LVO) acute ischemic stroke (AIS) patients treated with endovascular therapy (EVT).
Materials And Methods: Data were obtained from prospectively collected quality improvement stroke databases at six Canadian comprehensive stroke centres from March 11, 2020 to March 11, 2021.
Fully Automated and Explainable Measurement of Liver Surface Nodularity in CT: Utility for Staging Hepatic Fibrosis.
Acad Radiol
March 2025
National Institutes of Health Clinical Center, Building 10 Room 1C224, Bethesda, Maryland 20892-1182, USA (T.S.M., R.M.S.). Electronic address:
Rationale And Objectives: In the United States, cirrhosis was the 12th leading cause of death in 2016. Despite end-stage cirrhosis being irreversible, earlier stages of hepatic fibrosis can be reversed via early diagnosis and intervention. The objective is to investigate the utility of a fully automated technique to measure liver surface nodularity (LSN) for staging hepatic fibrosis (stages F0-F4).
View Article and Find Full Text PDFIntegration of Total Worker Health ® Training for Occupational Health and Safety Professionals With Efforts to Promote Worker Health, Safety, and Well-being in Mexico.
J Occup Environ Med
May 2024
From the Center for Health, Work and Environment, Colorado School of Public Health, Aurora, Colorado (C.E.B., D.J., L.T., N.V.S., M.G.G., K.V.H., D.C.S., M.V.D.); Center for Promotion of Health in the New England Workplace, University of Massachusetts, Lowell, Massachusetts (S.R.); Department of Environmental and Occupational Health, Colorado School of Public Health, Aurora, Colorado (L.T., N.V.S., M.V.D., J.B., L.S.N.); Department of Medicine, School of Medicine, University of Colorado Anschutz, Aurora, Colorado (L.S.N.); Instituto Mexicano del Seguro Social, Mexico City, Mexico (M.H.A., R.V.R., G.A.R.O., R.A.R.B., C.G.M.); and Universidad Rafael Landivar, Guatemala City, Guatemala (J.B.).
Objective: We sought to test whether a 2-week Total Worker Health (TWH) training mapped to TWH education competencies could be administered to a Mexican audience of occupational safety and health professionals and could lead to positive changes to knowledge and behaviors.
Methods: This study used robust program evaluation methods collected before and after each of the nine training days and at the end of the course.
Results: Overall course quality received a mean score of 4.
Arterial Thromboembolism in Patients With Atrial Fibrillation and CHADS-VASc Score 1: A Nationwide Study.
Circulation
March 2024
The Heart Center, Rigshospitalet (L.Ø., J.K.P., L.S.N., S.L.K., L.K., E.F.), University of Copenhagen, Denmark.
Background: Oral anticoagulation is suggested in patients with atrial fibrillation and a CHADS-VASc score ≥1 (congestive heart failure, hypertension, age ≥75 years, diabetes, stroke, vascular disease, age 65-74 years, and sex score). To assess granular differences within CHADS-VASc 1, the incidence of arterial thromboembolism according to CHADS-VASc 1 subgroups was examined.
Methods: The Danish National Patient Registry and the Danish Prescription Registry were linked on a nationwide level to identify patients with atrial fibrillation from 2000 to 2021 without oral anticoagulation and categorized according to CHADS-VASc score: CHADS-VASc 0 (male and female subjects); CHADS-VASc 1 (hypertension, heart failure, diabetes, vascular disease, and age 65-74 years); or CHADS-VASc 2 (age ≥75 years without other risk factors).
Liver surface nodularity and ascites are associated with mortality risk in acute alcohol-associated hepatitis.
Alcohol Clin Exp Res (Hoboken)
February 2024
Gastroenterology and Hepatology, University of California Davis School of Medicine, Sacramento, California, USA.
Background: Acute alcohol-associated hepatitis (AH) is associated with high mortality. CT-derived liver surface nodularity (LSN) is a robust prognostic biomarker in other chronic liver diseases. The aim of this study was to determine relationships between LSN, disease severity, and mortality in AH.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!